Please assess the completion status of the following clinical trial:

Trial Title: A Study of the Efficacy and Safety of Tocilizumab for Confirmed Rheumatoid Arthritis (RA) Participants in Clinical Practice

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with moderate-to-severe active rheumatoid arthritis (RA) for over 3 months~* Started on tocilizumab, with or without previous history of biological treatment~Exclusion Criteria:~* Pregnant or lactating women~* Treated with an investigational drug within 30 days prior to initiation of study drug~* Having a condition that, in the opinion of the investigator, could compromise the participant's safety or interfere with the study results

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Participants with confirmed rheumatoid arthritis (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).